结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
目的观察原发性高血压患者血浆组织因子途径、组织因子途径抑制物的变化及用依那普利、特拉唑嗪降压治疗后上述指标的变化。
Objective to observe the changes of tissue factor pathway (TFP) and tissue factor pathway inhibitor (TFPI) in essential hypertension and study the effects of enalapril and terazosin.
组织因子途径抑制物- 2；急性髓系白血病；血管内皮生长因子；白血病。
Tissue factor pathway inhibitor-2; Acute myelocytic leukemia; VEGF; leukemia.
组织因子途径抑制物- 2；急性髓系白血病；血管内皮生长因子；白血病。
Tissue factor pathway inhibitor-2; Acute myelocytic leukemia; VEGF; leukemia.
应用推荐